News
Million Women Study Supports Correlation between Hormone Replacement Therapy in Treating Menopause S
The Million Women Study is a study, conducted by UK researchers, of women's health analyzing data from more than one million women aged 50 and...
News
Abbott’s HUMIRA® (Adalimumab) Approved in Europe for Expanded Treatment of Crohn’s Disease (CD)
Abbott today announced that the European Commission (EC) has approved HUMIRA® (adalimumab) for the treatment of moderately active Crohn's disease (CD) in adult patients who...
News
Perrigo and Tris Pharma Launch Store Brand Version of DelsymÂ
Perrigo Company and Tris Pharma, Inc. today announced the commercial launch of a major new store brand product. The new product is equivalent to Delsym®...
News
First Accreditation of Chest Pain Center at Chinese Military Hospital Granted by ASCPC
Guangzhou General Hospital of Guangzhou Military Command announced that its Chest Pain Center was granted accreditation by the American Society of Chest Pain Centers (ASCPC). Professor...
News
CPhI South America Expands Offering for 2013, Announces Co-Location with Food Ingredients South Amer
 Leading events organiser, UBM Live, announced today at the opening of CPhI South America 2012 that it plans to expand its offering in 2013...
News
Alexza Pharmaceuticals Receives EU Certificate of GMP Compliance for its ADASUVEâ„¢ Manufacturing Fa
Alexza Pharmaceuticals, Inc. announced today that the company has received its EU Certificate of GMP Compliance of a Manufacturer. In May 2012, Alexza hosted an...
News
Segasist launches Crowd-Funding Round for Cloud-Based Quality Assurance in Cancer Treatment
Segasist Technologies, a Canadian software company developing next-generation image contouring platforms for biomedical applications, has launched a crowd funding campaign to bring its software Reconcillio...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
